CCM
RMD icon

Cobalt Capital Management’s ResMed RMD Stock Holding History

Cobalt Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-75,000
Closed -$4.23M – 76
2015
Q2 		$4.23M Buy
+75,000
New +$4.73M 0.39% 60

Other funds holding RMD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cobalt Capital Management's RMD Position: Q3 2015 in Review

Cobalt Capital Management sold out of ResMed (RMD) in Q3 2015, closing a stake of 75,000 shares — an estimated $4.23M sold.

Cobalt Capital Management first reported a position in RMD in Q2 2015 and held it in 1 quarter. The position peaked at $4.23M in Q2 2015. 313 funds tracked by Wall St. Rank hold RMD as of Q3 2015.

  • Cobalt Capital Management reported no remaining ResMed position as of Q3 2015 after selling out during the quarter.
  • Cobalt Capital Management sold 75,000 ResMed shares in Q3 2015, an estimated $4.23M.
  • Cobalt Capital Management first reported a position in ResMed in Q2 2015 and held it in 1 quarter.
  • Cobalt Capital Management's ResMed position peaked at $4.23M in Q2 2015.
  • 313 funds tracked by Wall St. Rank held ResMed as of Q3 2015.

Based on Cobalt Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.